Rep. Gilbert Ray Cisneros, Jr. Acquires Shares of Globus Medical, Inc. (NYSE:GMED)

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Globus Medical, Inc. (NYSE:GMED). In a filing disclosed on October 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Globus Medical stock on September 3rd. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Benchmark Electronics (NYSE:BHE) on 10/1/2026.
• Sold $1,001 – $15,000 in shares of Oxford Industries (NYSE:OXM) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of Semtech (NASDAQ:SMTC) on 9/29/2026.
• Sold $15,001 – $50,000 in shares of ITT (NYSE:ITT) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Tandem Diabetes Care (NASDAQ:TNDM) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Cytokinetics (NASDAQ:CYTK) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of YETI (NYSE:YETI) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of AtriCure (NASDAQ:ATRC) on 9/29/2026.

Globus Medical Trading Down 0.0%

Shares of NYSE:GMED opened at $76.21 on Wednesday. Globus Medical, Inc. has a 1-year low of $56.96 and a 1-year high of $101.40. The stock has a market capitalization of $10.23 billion, a P/E ratio of 15.50, a P/E/G ratio of 1.23 and a beta of 0.96. The business has a 50-day moving average price of $78.91 and a two-hundred day moving average price of $81.59.

Globus Medical (NYSE:GMED) last issued its earnings results on Thursday, August 6th. The medical device company reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.24. The company had revenue of $789.61 million for the quarter, compared to analyst estimates of $782.88 million. Globus Medical had a net margin of 17.02% and a return on equity of 14.57%. The company’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.86 EPS. Globus Medical has set its FY 2026 guidance at 4.950-5.050 EPS. As a group, equities analysts predict that Globus Medical, Inc. will post 4.99 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on GMED shares. Wells Fargo & Company cut their price objective on shares of Globus Medical from $103.00 to $99.00 and set an “overweight” rating on the stock in a report on Friday, August 7th. Zacks Research raised shares of Globus Medical from a “hold” rating to a “strong-buy” rating in a report on Monday, August 10th. Royal Bank Of Canada dropped their target price on shares of Globus Medical from $115.00 to $85.00 and set an “outperform” rating for the company in a research report on Thursday, October 1st. BMO Capital Markets initiated coverage on Globus Medical in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $94.00 price target on the stock. Finally, UBS Group began coverage on Globus Medical in a research note on Tuesday, July 28th. They issued a “neutral” rating and a $82.00 price target on the stock. Three research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, Globus Medical presently has a consensus rating of “Moderate Buy” and an average target price of $99.46.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Elevation Wealth Partners LLC lifted its holdings in shares of Globus Medical by 2,178.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 319 shares of the medical device company’s stock valued at $25,000 after purchasing an additional 305 shares in the last quarter. Continuum Advisory LLC acquired a new position in shares of Globus Medical in the 2nd quarter valued at approximately $25,000. Summit Securities Group LLC bought a new stake in Globus Medical during the 1st quarter worth approximately $48,000. Root Financial Partners LLC increased its stake in Globus Medical by 291.5% during the 1st quarter. Root Financial Partners LLC now owns 779 shares of the medical device company’s stock worth $67,000 after purchasing an additional 580 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in Globus Medical by 111.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 1,199 shares of the medical device company’s stock worth $103,000 after purchasing an additional 632 shares in the last quarter. Institutional investors and hedge funds own 95.16% of the company’s stock.

Insider Activity at Globus Medical

In other Globus Medical news, Director Stephen Zarrilli sold 25,000 shares of Globus Medical stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $87.04, for a total value of $2,176,000.00. Following the transaction, the director owned 25,000 shares of the company’s stock, valued at approximately $2,176,000. The trade was a 50.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director James R. Tobin sold 30,000 shares of Globus Medical stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $74.58, for a total transaction of $2,237,400.00. Following the completion of the transaction, the director directly owned 15,000 shares in the company, valued at approximately $1,118,700. The trade was a 66.67% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 18.38% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Globus Medical Company Profile

Globus Medical, Inc is a medical device company that develops musculoskeletal solutions for surgeons, hospitals and ambulatory surgery centers. Its primary focus is the design, development and commercialization of products used in spinal surgery, including implants, instruments, navigation systems and robotic-assisted technologies.

The company’s portfolio includes the ExcelsiusGPS robotic navigation platform, Excelsius3D imaging technology, spinal implants and systems for procedures such as deformity correction, degenerative spine treatment and minimally invasive surgery.